Inactivation and Inducible Oncogenic Mutation of p53 in Gene Targeted Pigs
Open Access
- 5 October 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (10), e43323
- https://doi.org/10.1371/journal.pone.0043323
Abstract
Mutation of the tumor suppressor p53 plays a major role in human carcinogenesis. Here we describe gene-targeted porcine mesenchymal stem cells (MSCs) and live pigs carrying a latent TP53R167H mutant allele, orthologous to oncogenic human mutant TP53R175H and mouse Trp53R172H, that can be activated by Cre recombination. MSCs carrying the latent TP53R167H mutant allele were analyzed in vitro. Homozygous cells were p53 deficient, and on continued culture exhibited more rapid proliferation, anchorage independent growth, and resistance to the apoptosis-inducing chemotherapeutic drug doxorubicin, all characteristic of cellular transformation. Cre mediated recombination activated the latent TP53R167H allele as predicted, and in homozygous cells expressed mutant p53-R167H protein at a level ten-fold greater than wild-type MSCs, consistent with the elevated levels found in human cancer cells. Gene targeted MSCs were used for nuclear transfer and fifteen viable piglets were produced carrying the latent TP53R167H mutant allele in heterozygous form. These animals will allow study of p53 deficiency and expression of mutant p53-R167H to model human germline, or spontaneous somatic p53 mutation. This work represents the first inactivation and mutation of the gatekeeper tumor suppressor gene TP53 in a non-rodent mammal.Keywords
This publication has 31 references indexed in Scilit:
- Homozygous and Heterozygous p53 Knockout Rats Develop Metastasizing Sarcomas with High FrequencyThe American Journal of Pathology, 2011
- Mutant p53 Gain-of-Function in CancerCold Spring Harbor Perspectives in Biology, 2010
- Engineering Cell-permeable ProteinJournal of Visualized Experiments, 2009
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical UseCold Spring Harbor Perspectives in Biology, 2009
- Polyclonal antibody to porcine p53 protein: A new tool for studying the p53 pathway in a porcine modelBiochemical and Biophysical Research Communications, 2008
- Maximizing mouse cancer modelsNature Reviews Cancer, 2007
- p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosisCancer Cell, 2003
- Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: A tool for efficient genetic engineering of mammalian genomesProceedings of the National Academy of Sciences of the United States of America, 2002
- Cancer phenotype correlates with constitutional TP53 genotype in families with the Li–Fraumeni syndromeOncogene, 1998
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994